Novartis AG, the Switzerland-based pharmaceutical company, released its 2020 preferred panel of global and U.S. law firms with strict staffing requirements that its firms believe will help create a more diverse legal profession.

This is the third iteration of its preferred panel based on diversity and inclusion efforts. The firms that comprise Novartis’ 2020 preferred panel are: Alston & Bird; Arnold & Porter Kaye Scholer; Bird & Bird; Brinks Gilson Lione; Freshfields Bruckhaus Deringer; Gibson, Dunn & Crutcher; Goodwin Procter; Greenberg Traurig; Hogan Lovells; Kirkland & Ellis; Latham & Watkins; Linklaters; Mayer Brown; Morgan, Lewis & Bockius; Morrison & Foerster; Munger, Tolles & Olson; O’Melveny & Myers; Sullivan & Cromwell; Troutman Sanders; Williams & Connolly; Wilmer Cutler Pickering Hale and Dorr; and Womble Bond Dickinson.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]